Chimeric antigen receptors on regulatory T cells as a treatment strategy in auto-immune diseases.
Chimeric antigen receptors on regulatory T cells as a treatment strategy in auto-immune diseases.
调节性 T 细胞上的嵌合抗原受体作为自身免疫性疾病的治疗策略。
批准号：
437200
负责人：
Dasari Harika
金额：
$7.65万
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2020
资助国家：
加拿大
项目状态：
已结题
起止时间：
2020-11-01 至 2023-11-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This work builds on a novel treatment that uses a special immune cell called a regulatory T cell, which suppresses immune responses. Regulatory T cells (Tregs) are the policemen of the immune system. They shut the party down before it gets too rowdy, thus
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Innovative Immunotherapy Approach in Chimeric Antigen Receptor based therapy for acute leukemia using transplantation of genetically modified hematopoietic stem cells.
-
批准号：406459
-
项目类别：Studentship Programs
-
资助金额：$1.27万
-
财政年份：2018
-
负责人：Dasari Harika
-
依托单位：
海外基金
